home / stock / mnov / mnov news


MNOV News and Press, MediciNova Inc. From 08/14/25

Stock Information

Company Name: MediciNova Inc.
Stock Symbol: MNOV
Market: NASDAQ
Website: medicinova.com

Menu

MNOV MNOV Quote MNOV Short MNOV News MNOV Articles MNOV Message Board
Get MNOV Alerts

News, Short Squeeze, Breakout and More Instantly...

MNOV - Expected US Company Earnings on Thursday, August 14th, 2025

Century Therapeutics Inc. (IPSC) is expected to report $-0.38 for Q2 2025 Birchtech Corp Com (BCHT) is expected to report for Q2 2025 Cellectar Biosciences Inc. (CLRB) is expected to report $-3.6 for Q2 2025 Acuren Corporation (TIC) is expected to report for quarter end 2025-06-30 ...

MNOV - Expected earnings - MediciNova Inc.

MediciNova Inc. (MNOV) is expected to report $-0.07 for Q2 2025

MNOV - MNOV - Historical Price Movements Surrounding Earnings

2025-08-13 18:45:08 ET MediciNova, Inc. (MNOV) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 2.96%. The average open to low on the day of earnings was -2.46%. The average open to close...

MNOV - MNOV - Historical Earnings Price Analysis

2025-08-13 18:40:07 ET MediciNova, Inc. (MNOV) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in MNOV stock price following earnings has averaged ±2.19% , with a median of 1.58%. The...

MNOV - MediciNova signs standby equity purchase agreement for up to $30M

2025-08-01 02:20:22 ET More on MediciNova Seeking Alpha’s Quant Rating on MediciNova Historical earnings data for MediciNova Financial information for MediciNova Read the full article on Seeking Alpha For further details see: MediciNova sig...

MNOV - MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million

LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces a Standby Equity Purchase ...

MNOV - MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials

LA JOLLA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), today provides an update on the enrol...

Previous 10 Next 10